Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Lasseter

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patientsV M Campese, K C Lasseter, C M Ferrario, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjectsM Iwamoto, L A Wenning, A S Petry, et al.
Journal of Human Hypertension|April 1, 1997
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertensionR Fiddes, J Blumenthal, J E Dawson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in menJ I Schwartz, A Van Hecken, P J De Schepper, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 1, 2006
Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjectsE M Migoya, A Bergman, D Hreniuk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bileS K Balani, X Xu, V Pratha, et al.
Annals of Internal Medicine|July 6, 2000
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trialS K Swan, D W Rudy, K C Lasseter, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patientsV M Campese, K C Lasseter, C M Ferrario, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjectsM Iwamoto, L A Wenning, A S Petry, et al.
Journal of Human Hypertension|April 1, 1997
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertensionR Fiddes, J Blumenthal, J E Dawson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in menJ I Schwartz, A Van Hecken, P J De Schepper, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 1, 2006
Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjectsE M Migoya, A Bergman, D Hreniuk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bileS K Balani, X Xu, V Pratha, et al.
Annals of Internal Medicine|July 6, 2000
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trialS K Swan, D W Rudy, K C Lasseter, et al.
Pageof 6